Steven J Van Laere
Overview
Explore the profile of Steven J Van Laere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
1707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie X, Chauhan G, Edupuganti R, Kogawa T, Park J, Tacam M, et al.
Cancer Res Commun
. 2024 Jan;
4(1):236.
PMID: 38282551
No abstract available.
2.
Xie X, Chauhan G, Edupuganti R, Kogawa T, Park J, Tacam M, et al.
Cancer Res Commun
. 2023 Jun;
3(6):1078-1092.
PMID: 37377604
Significance: These findings indicate that MELK is a driver of aggressiveness and metastasis in TNBC.
3.
Wang X, Semba T, Manyam G, Wang J, Shao S, Bertucci F, et al.
Sci Adv
. 2022 Dec;
8(50):eabn7983.
PMID: 36525493
Inflammatory breast cancer (IBC), the most aggressive breast cancer subtype, is driven by an immunosuppressive tumor microenvironment (TME). Current treatments for IBC have limited efficacy. In a clinical trial (NCT01036087),...
4.
Gevaert A, Witvrouwen I, Van Craenenbroeck A, Van Laere S, Boen J, Van De Heyning C, et al.
Eur J Prev Cardiol
. 2021 Sep;
28(15):1722-1733.
PMID: 34508569
Aims: In patients with heart failure with preserved ejection fraction (HFpEF), exercise training improves the quality of life and aerobic capacity (peakV·O2). Up to 55% of HF patients, however, show...
5.
Witvrouwen I, Gevaert A, Possemiers N, Beckers P, Vorlat A, Heidbuchel H, et al.
Eur J Prev Cardiol
. 2021 Mar;
28(15):1673-1681.
PMID: 33742210
Aims: Exercise training is a powerful adjunctive therapy in patients with heart failure with reduced ejection fraction (HFrEF), but ca. 55% of patients fail to improve VO2peak. We hypothesize that...
6.
Iwase T, Harano K, Masuda H, Kida K, Hess K, Wang Y, et al.
BMC Cancer
. 2020 May;
20(1):430.
PMID: 32423453
Background: The purpose of this study was to determine the prognostic role of hormone receptor (HR) on inflammatory breast cancer (IBC) to elucidate its aggressive biological behavior. Methods: We evaluated...
7.
Rypens C, Marsan M, Van Berckelaer C, Billiet C, Melis K, Lopez S, et al.
Breast Cancer Res Treat
. 2020 Feb;
180(2):385-395.
PMID: 32043194
Purpose: Inflammatory breast cancer (IBC) is an aggressive form of breast cancer with elevated metastatic potential, characterized by tumor emboli in dermal and parenchymal lymph vessels. This study has investigated...
8.
Everaert B, Van Laere S, Lembrechts R, Hoymans V, Timmermans J, Vrints C
Stem Cells Int
. 2019 Jun;
2019:9545261.
PMID: 31191690
Background: Circulating angiogenic cells (CAC) have been identified as important regulators of vascular biology. However, there is still considerable debate about the genotype and function of CAC. Methods And Results:...
9.
Cristofanilli M, Pierga J, Reuben J, Rademaker A, Davis A, Peeters D, et al.
Crit Rev Oncol Hematol
. 2019 Feb;
134:39-45.
PMID: 30771872
Background: The heterogeneity of metastatic breast cancer (MBC) necessitates novel biomarkers allowing stratification of patients for treatment selection and drug development. We propose to use the prognostic utility of circulating...
10.
De Laere B, Oeyen S, Mayrhofer M, Whitington T, Van Dam P, Van Oyen P, et al.
Clin Cancer Res
. 2018 Sep;
25(6):1766-1773.
PMID: 30209161
Purpose: To infer the prognostic value of simultaneous androgen receptor () and profiling in liquid biopsies from patients with metastatic castration-resistant prostate cancer (mCRPC) starting a new line of signaling...